These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6267504)

  • 1. Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
    Zetler G
    Neuropharmacology; 1981 Mar; 20(3):277-83. PubMed ID: 6267504
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
    Zetler G
    Neurosci Lett; 1981 Jul; 24(2):175-80. PubMed ID: 6265841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.
    Zetler G
    Eur J Pharmacol; 1980 Aug; 66(1):137-9. PubMed ID: 6250861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam.
    Zetler G
    Eur J Pharmacol; 1980 Jul; 65(2-3):297-300. PubMed ID: 6249626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).
    Zetler G
    Neuropharmacology; 1980 May; 19(5):415-22. PubMed ID: 6248810
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
    Zetler G
    Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.
    Zetler G
    Peptides; 1982; 3(4):701-4. PubMed ID: 6291014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
    Zetler G
    Neuropharmacology; 1985 Mar; 24(3):251-9. PubMed ID: 2859544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol.
    Zetler G
    Neuropharmacology; 1981 Jul; 20(7):681-6. PubMed ID: 7195998
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central effects of ceruletide analogues.
    Zetler G
    Peptides; 1981; 2 Suppl 2():65-9. PubMed ID: 6283499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
    Zetler G
    Eur J Pharmacol; 1984 Jul; 102(2):333-40. PubMed ID: 6090162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol.
    Vasar E; Soosaar A; Harro J; Lang A
    Eur Neuropsychopharmacol; 1992 Dec; 2(4):447-54. PubMed ID: 1490096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caerulein and its analogues: neuropharmacological properties.
    Zetler G
    Peptides; 1985; 6 Suppl 3():33-46. PubMed ID: 3913910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
    Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
    Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G
    Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.
    Harro J; Põld M; Vasar E
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):62-7. PubMed ID: 2314484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
    Zetler G
    Neuropharmacology; 1983 Jun; 22(6):757-66. PubMed ID: 6310434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.
    Kuribara H
    Psychopharmacology (Berl); 1995 Jul; 120(1):75-80. PubMed ID: 7480538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
    Worms P; Martinez J; Briet C; Castro B; Biziere K
    Eur J Pharmacol; 1986 Mar; 121(3):395-401. PubMed ID: 3699101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.